Access highlights clinical benefits of MuGard at ESMO conference Gain access to Pharmaceuticals.

Access highlights clinical benefits of MuGard at ESMO conference Gain access to Pharmaceuticals, Inc. , a biopharmaceutical business focusing on products for tumor and supportive treatment, announced the highlights from a poster display on European clinical experience of MuGard as of this year’s European Culture of Medical Oncology Meeting in Milan, Italy. Related StoriesSausages With Antioxidants From Berries To Prevent CancerCrucial change in solitary DNA base predisposes children to aggressive type of cancerFDA grants accelerated acceptance for Tagrisso to treat patients with advanced NSCLC These additional findings out of Europe are very thrilling and reinforce our belief in the scientific benefits that MuGard can offer patients undergoing radiation and chemotherapy, said Jeffrey Davis, CEO of Access Pharmaceuticals generic for cialis .